about
Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cellsAn integrated approach for experimental target identification of hypoxia-induced miR-210Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgeryIndobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanismS 35171 exerts protective effects in spontaneously hypertensive stroke-prone rats by preserving mitochondrial function[Cardiovascular proteomics: challenges and opportunities for cardiologists of the future].Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project.Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor.Data for proteomic analysis of Human monocyte-derived macrophagesProteome of endothelial cell-derived procoagulant microparticles.Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts.On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients.Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients.Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function.Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.Oxidized LDLs influence thrombotic response and cyclooxygenase 2.A mass spectrometry-based workflow for the proteomic analysis of in vitro cultured cell subsets isolated by means of laser capture microdissection.Human monocyte-derived macrophages are heterogenous: Proteomic profile of different phenotypes.Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone ratsA preliminary study on human placental tissue impaired by gestational diabetes: a comparison of gel-based versus gel-free proteomics approaches.The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases.Normal human mitral valve proteome: A preliminary investigation by gel-based and gel-free proteomic approaches.Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors.Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve.Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failure.Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control.Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins.Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.Cardiomyocyte death induced by ischaemic/hypoxic stress is differentially affected by distinct purinergic P2 receptors.Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death.Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells.Corrigendum to "Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor" [Data Brief 3 (2015) 117-119]Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment.Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.Proteome of platelets in patients with coronary artery disease.Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.Altered iron homeostasis in an animal model of hypertensive nephropathy: stroke-prone rats.
P50
Q24293234-C531C147-419D-4618-B206-0FDCA0BE1849Q24646947-EDC7C44D-AEDB-45BF-A1B4-52D7D2483AD5Q28242672-E639C664-22A1-4B4A-A3C8-497F4D6382FEQ28271620-DF44D4FF-FD85-487C-B2F4-B7CB24AF6638Q28564722-C0B91CF4-2F40-41D4-91C6-D6AA95FFAF7DQ30352273-890AF4DF-37BB-4285-8163-E84FF788A319Q30619949-F4712179-5DC9-4F7C-A4A0-DC298A62C324Q30983279-C7E42A8C-C441-49B3-BDBE-5558348879D9Q30983391-FE290EF8-EF2F-4847-BD48-EB9A40299212Q33225051-8FE0E9FF-94A1-45A0-B8B1-13C53F06CC2FQ33233799-19C206A4-EC84-48DA-9173-BCE4F5E4264BQ33295189-C4332D2D-F452-44D8-ABB4-839A127916BEQ33310263-7483B328-B0D5-46C4-A982-3FA4DC61B555Q34273494-2F6E6AE0-59C0-4CF9-B1F5-D09D4032CCC0Q34712791-406B3DE2-71AA-4F52-839D-4DA4E474DFC8Q34904829-F9E1EABE-2188-4CEA-B6C2-CEE1504DA2AAQ35122121-274F371B-EBC3-4384-9E13-3D0CDB526F51Q35598515-8998BC4D-3A5F-413A-BA7F-F53712322597Q35691575-80AF16FA-B5B8-471C-8ECA-BDF65ED17AD2Q36078489-5DF3FD85-0CEA-4457-B0DD-E9D976877E08Q38268586-6DFE340F-7CEA-40FA-8D21-F9FCD822A75CQ38389725-A60F623F-DE52-4866-9A72-EAF7630764CCQ38494493-9C37F752-14C8-46AE-AB3F-9AEFFD5DDD7DQ38707231-E46DB048-F327-4C72-BD05-C685FFAB995FQ38896366-02E5FC04-3AFE-48EC-AC6E-500BFC3AB53FQ38911080-203B329D-B8B4-43A9-85EE-EA6A1650A869Q39174369-CF949FB0-AB6E-45D5-BFEE-D703BCA96958Q39316007-4D538863-6BAA-41BA-A689-695EC7870E76Q39506109-80D71B31-4C49-4929-B87C-9784D59EA036Q39852189-FF3E79DD-250E-46BA-BD0C-F24B3A90E8CCQ40170492-FDE7828C-0D8E-4554-A640-09C7D0047104Q40359371-8997F8B5-6193-420A-9DA4-7B34502D187DQ40603927-B6D33A2D-DC1D-4546-897A-0C599734E901Q42602246-B847EADE-DDD9-4A5E-9EC4-7579C9525667Q42660924-4E65EA79-D003-4A72-80DF-A6F83EC3CA6AQ42784754-F7F9AC9B-E19D-4408-85AD-223CB356B4C6Q43120732-D85317A1-0C57-448C-B86C-925C2AB83C8CQ43130993-72AE14F3-DB5E-48AE-855D-E07BFFD5E404Q43292243-079854D5-C124-44AF-A40F-B868B45C147AQ43514463-EC5DB049-811F-4E3A-91FC-618BC95497D8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina Banfi
@ast
Cristina Banfi
@en
Cristina Banfi
@es
Cristina Banfi
@nl
Cristina Banfi
@sl
type
label
Cristina Banfi
@ast
Cristina Banfi
@en
Cristina Banfi
@es
Cristina Banfi
@nl
Cristina Banfi
@sl
prefLabel
Cristina Banfi
@ast
Cristina Banfi
@en
Cristina Banfi
@es
Cristina Banfi
@nl
Cristina Banfi
@sl
P1053
G-6362-2018
P106
P1153
6603951888
P21
P31
P3829
P496
0000-0003-3346-9879